Vai al contenuto principale della pagina

Parkinson's disease / / edited by E. Ronken and G.J.M. van Scharrenburg



(Visualizza in formato marc)    (Visualizza in BIBFRAME)

Titolo: Parkinson's disease / / edited by E. Ronken and G.J.M. van Scharrenburg Visualizza cluster
Pubblicazione: Amsterdam ; ; Washington, DC, : IOS Press, c2002
Edizione: 1st ed.
Descrizione fisica: 1 online resource (168 p.)
Disciplina: 616.8/33
Soggetto topico: Parkinson's disease
Altri autori: RonkenE  
ScharrenburgG. J. M. van  
Note generali: "The First Solvay Pharmaceuticals Conference on "Parkinson's Disease" was held in Como from October 25 to 27, 2000"--Pref.
Nota di bibliografia: Includes bibliographical references and index.
Nota di contenuto: Cover -- Title page -- Preface -- List of Contributors -- Contents -- Conference Preface -- Key-note lecture - Movement Disorders: An Overview -- Part I: Parkinson's Disease - Symptoms, Models and Treatment -- Neurochemical Changes in Parkinson's Disease -- Psychosis and Depression in Parkinson's Disease -- Experimental Models of Parkinson's Disease -- SLV308: A Novel Antiparkinsonian Agent with Antidepressant and Anxiolytic Properties -- Adenosine A[sub(2A)] Receptor Antagonists and Parkinson's Disease -- Part II: Understanding and Influencing Neuro-Degeneration -- Bioenergetics in Neurodegeneration -- Neuronal Cell Death and Apoptosis in Neurodegenerative Diseases -- Animal Models of Neurodegeneration in Parkinson's Disease -- Parkinsonian Features of the Ataxia-Telangiectasia and of the Atm-Deficient Mouse -- Neuroprotection in Parkinson's Disease through Selective Gene Induction -- Part III: Towards Neuroprotective Efficacy -- The RET-Dependent Neuroprotective Effects of GDNF are Mediated by Activation of Proteinkinase B (PKB)/AKT -- An Immortalized Neuronal Cell Line Derived from the Substantia Nigra of an Adult Rat: Application to Cell Transplant Therapy -- Lentiviral Vector Delivery of GDNF in Primate Models of Parkinson's Disease Prevents Neurodegeneration -- Design of Clinical Studies for Neuroprotective Efficacy -- Regulation of Glial Cell Line-Derived Neurotrophic Factor (GDNF) for Dopamine Conservation in Models for Parkinson's Disease -- Concluding Remarks -- Author Index -- A -- B -- C -- D -- E -- F -- H -- J -- K -- L -- M -- N -- O -- P -- R -- S -- T -- V -- W.
Sommario/riassunto: This volume contains the proceedings of the first Solvay Pharmaceuticals Research Symposium, and is dedicated to Parkinson's disease. It provides an update of clinical and preclinical research.
Titolo autorizzato: Parkinson's disease  Visualizza cluster
ISBN: 600-00-0515-6
9786610505364
1-280-50536-2
1-60129-451-4
Formato: Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione: Inglese
Record Nr.: 9910808219803321
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Serie: Solvay Pharmaceuticals Conferences ; ; v. 1.